Yoel Levinsky

Dr. Yoel Levinsky

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2022 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
LGLotem Goldberg
Lotem Goldberg
AZAdi Ziv
Adi Ziv
YVYoav Vardi
Yoav Vardi
SHShai Hadas
Shai Hadas
TZTarek Zuabi
Tarek Zuabi
YLYoel Levinsky
Yoel Levinsky

24 February 2024 in Pathogens
Verified
Journal Article
Open access
PDF file
VZVered Shkalim Zemer
Vered Shkalim Zemer
SAShai Ashkenazi
Shai Ashkenazi
YLYoel Levinsky
Yoel Levinsky
YRYael Richenberg
Yael Richenberg
EJEyal Jacobson
Eyal Jacobson
ACAvner Herman Cohen
Avner Herman Cohen
Urinary tract infections (UTIs) in childhood are common and are associated with considerable acute morbidity and long-term complications. The need for updated data to optimize empiric antibiotic therapy is crucial. We aimed to investigate the pathogens causing pediatric community acquired UTIs, their correlation with demographic characteristics, and trends in their antimicrobial resistance. This nationwide cross-sectional study included all 53,203 children (<18 years) diagnosed with UTI in community outpatient clinics in the following selected years: 2007, 2011, 2015, 2019 and 2021. Escherichia coli (E. coli) (82.1%) was the most common uropathogen, followed by Enterobacter, Klebsiella, Proteus, Pseudomonas, and Enterococcus species. The bacterial distribution displayed statistically significant (p < 0.0001) gender- and sector-specific patterns with a higher relative prevalence of non-E. coli UTI in Jewish and males. The rate of extended-spectrum beta-lactamase-positive E. coli increased substantially and significantly (p < 0.001) from only 6.1% in 2007 to 25.4% in 2021. Most non-E. coli uropathogens exhibited resistance to commonly used empiric antibiotics for UTIs in children. These findings are significant in guiding optimal empiric antibiotic treatment for pediatric community acquired UTIs. The resistance of uropathogens to antimicrobials is region- and time-dependent. Therefore, the periodic and local assessment of antibiotic resistance trends is essential to update guidelines and provide the most appropriate antibacterial therapy for children with UTIs.

15 June 2023 in Journal of Pediatric Urology
Verified
Journal Article
Closed access
VZVered Shkalim Zemer
Vered Shkalim Zemer
HCHerman Avner Cohen
Herman Avner Cohen
YRYael Richenberg
Yael Richenberg
MGMaya Gerstein
Maya Gerstein
IAIfat Atias
Ifat Atias
DMDavid Ben Meir
David Ben Meir

2 May 2023 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
VZVered Shkalim Zemer
Vered Shkalim Zemer
MHMoshe Hoshen
Moshe Hoshen
YLYoel Levinsky
Yoel Levinsky
YRYael Richenberg
Yael Richenberg
NYNoga Yosef
Noga Yosef
ACAvner Herman Cohen
Avner Herman Cohen

9 January 2024 in Arthritis & Rheumatology
Verified
Journal Article
Open access
MBMerav Birk‐Bachar
Merav Birk‐Bachar
HCHadar Cohen
Hadar Cohen
ESEfrat Sofrin‐Drucker
Efrat Sofrin‐Drucker
NKNesia Kropach‐Gilad
Nesia Kropach‐Gilad
NONaama Orenstein
Naama Orenstein
LHLiora Harel
Liora Harel
Objective: Cryopyrin‐associated periodic syndromes (CAPS), also known as NLRP3‐associated autoinflammatory diseases, are a spectrum of rare autoinflammatory diseases caused by gain‐of‐function variants in the NLRP3 gene, resulting in inflammasome hyperactivation and dysregulated release of interleukin‐1β (IL‐1β). Many patients with CAPS develop progressive sensorineural hearing loss (SNHL) because of cochlear autoinflammation, which may be the sole manifestation in rare cases. This study was undertaken to establish the suspected diagnosis of CAPS in a family presenting with autosomal‐dominant progressive/acute SNHL and a novel missense variant in the NLRP3 gene of unknown significance (NM_001079821.3:c.1784G>A p.Ser595Asn).Methods: We conducted an ex vivo functional assessment of the NLRP3 inflammasome in heterozygous individuals (n = 10) and healthy family members (n = 5).Results: The assay revealed hyperactivation of the inflammasome among heterozygous individuals, supporting the hypothesis that this missense variant is a pathogenic gain‐of‐function variant. Administration of IL‐1 receptor antagonist resulted in a substantial clinical improvement among pediatric patients, who exhibited near resolution of hearing impairment within 1 to 3 months of treatment.Conclusion: Our findings highlight the crucial role of early diagnosis and treatment with an anti–IL‐1 agent in reversing cochlear damage. Furthermore, our results suggest that high‐ and ultrahigh‐frequency ranges need to be included in the auditory assessment to enable early detection of subclinical SNHL. Finally, incorporating functional inflammasome assessment as part of the clinical evaluation could establish the diagnosis in inconclusive cases. image

20 October 2020 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
RGRachel Gavish
Rachel Gavish
IKIrit Krause
Irit Krause
LGLotem Goldberg
Lotem Goldberg
EBEfraim Bilavsky
Efraim Bilavsky
GKGili Kadmon
Gili Kadmon
YLYoel Levinsky
Yoel Levinsky
A significant drop was found in the number of hospitalizations due to bacterial infections among children during the first peak period of COVID-19 in Israel. There was a 77% decrease in serious bacterial infections, and ≥50% decrease in most types of bacterial infections, especially osteoarticular and skin infections, followed by pneumonia and ENT infections.